News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 109–144
- Matches
- 746
- Sources here
- 18
- Companies here
- 18
Active search
746 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Repligen (RGEN) Could Be 10% Below Fair Value On Mixed Q2 Earnings
Repligen (RGEN) recently reported mixed Q2 2026 earnings, showing higher revenue but lower net income and EPS year-over-year. Despite this, the stock has seen strong recent momentum, with a 90-day return of 41.4% and a 1-year return of 47.09%, positioning it about 10% below …
Republic Services Lost Volume in Q2 Earnings. Free Cash Flow Jumped 21% Anyway.
Republic Services (RSG) exceeded Q2 expectations for revenue and adjusted EPS, raising its full-year guidance despite a 1.6% drop in organic volume. The company prioritized price over volume, pruning low-return residential work and expanding margins. Free cash flow surged by 21% in Q2, and …
Replimune in the spotlight: Earnings loom days after FDA approval
Replimune Group Inc. is set to report its fiscal fourth-quarter earnings, marking its first financial update since receiving FDA approval for its melanoma therapy, Tudriqev. Despite the regulatory success, analysts have significantly lowered EPS estimates, though most still rate the stock a "Buy" with …
IRSA Inversiones Number of Employees 2026 | Employee Count & Headcount Data
IRSA Inversiones y Representaciones SA (IRSA) had approximately 1,832 employees worldwide as of March 2026, marking a 16.1% growth from 2023. The company is actively hiring, though its job postings declined significantly in 2026. Most of its workforce is based in South America, with …
Empowered Funds LLC Makes New $1.05 Million Investment in Old Republic International Corporation $ORI
Empowered Funds LLC has made a new investment of $1.05 million in Old Republic International Corporation (NYSE:ORI), acquiring 26,413 shares. This comes as institutional investors collectively own 70.9
Price to earnings forward of Sarepta Therapeutics, Inc. – BX:AB3A
This article provides financial data for Sarepta Therapeutics, Inc. under the ticker BX:AB3A on the BX Swiss exchange. It specifically highlights the "Price to earnings forward" metric for the company. The page appears to be a financial data snippet from TradingView, focusing on market …
(AXR) as a Liquidity Pulse for Institutional Tactics
This article analyzes Amrep Corporation (NYSE: AXR) using AI models to provide insights for institutional trading strategies. It highlights weak near and mid-term sentiment potentially challenging a positive long-term outlook and identifies elevated downside risk. The report offers specific trading strategies for long, breakout, …
Sarepta Therapeutics, Inc. Revenue Breakdown – BX:AB3A
Sarepta Therapeutics, Inc. (BX:AB3A) generated 1.74 billion CHF in revenue last year, primarily from its RNA-targeted Therapeutics, Small Interfering RNA Platform, Gene Therapy, and Other Genetic Therapeutic Modalities segment, which contributed 1.48 billion CHF. The United States was the largest regional contributor, accounting for …
Two Rejections, Messy Process: Replimune Finally Secures FDA Approval for Skin Cancer Treatment
The FDA has granted accelerated approval to Replimune Group Inc. for its novel oncolytic immunotherapy, Tudriqev, for advanced cutaneous melanoma. This approval comes after previous rejections and relies on promising clinical trial results from the IGNYTE trial, which showed a 24.2% objective response rate …
Is Repligen’s (RGEN) Rising Revenue But Softer Earnings Rewriting Its Profitability Story?
Repligen Corporation (RGEN) reported rising revenue in Q2 2026, reaching US$204.13 million, but net income and earnings per share fell compared to the previous year. This performance highlights a conflict between increased demand and pressure on profitability due to the company's cost structure and …
AMREP Corporation (AXR) stock price, news, quote and history
This article provides a detailed financial overview of AMREP Corporation (AXR), including its current stock price, historical data, and key financial metrics. It highlights the company's operations in land development and homebuilding, its performance against the S&P 500, and analyst insights with price targets …
Intrepid Potash Q2 Earnings Call Highlights
Key Points Interested in Intrepid Potash, Inc? Here are five stocks we like better. Profitability improved in Q2: Adjusted EBITDA rose to $17.5 million from $13.8 million, while gross margin increased 35% to $16.6 million, driven by stronger Trio margins and improved potash operations. …
KORU Medical Systems, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
KORU Medical Systems (NASDAQ:KRMD) surpassed revenue expectations in its recent quarterly report, though its stock saw a 14% drop. Analysts maintained their revenue forecasts for 2026 at US$48.1m, an expected 6.6% increase, but modestly raised loss-per-share forecasts to US$0.047. Despite these adjustments, the consensus …
How Republic Services Inc. (RSG) Affects Rotational Strategy Timing
This article from Stock Traders Daily analyzes Republic Services Inc. (RSG) using AI models to provide trading strategies and signal analysis. It highlights weak near and mid-term sentiment but a neutral long-term outlook, identifying a significant risk-reward setup. The report details position, momentum breakout, …
Sarepta Therapeutics (SRPT) Brings In Michael Severino As Chief Executive Officer
Sarepta Therapeutics has appointed Michael Severino as its new Chief Executive Officer and a member of its Board of Directors. Severino, with a strong background in senior leadership and research in biotech, joins the company as it navigates a revenue reset, with Q2 2026 …
Law Offices of Frank R. Cruz Encourages Replimune Group, Inc. (REPL) Shareholders To Inquire About Securities Fraud Class Action
The Law Offices of Frank R. Cruz has filed a class action lawsuit against Replimune Group, Inc. (REPL) on behalf of shareholders who purchased securities between October 20, 2025, and April 10, 2026. The lawsuit alleges that Replimune made materially false and misleading statements …
Republic Services (NYSE:RSG) Announces Quarterly Earnings Results, Beats Estimates By $0.04 EPS
Republic Services (NYSE:RSG) reported strong quarterly earnings, beating analyst estimates with an EPS of $1.85 and revenue of $4.43 billion, marking a 4.6% increase year-over-year. The company also raised its quarterly dividend to $0.67 per share and updated its full-year guidance, despite some analyst …
Telkom Indonesia (NYSE: TLK) sets Sept. 30, 2026 extraordinary shareholder meeting
Telkom Indonesia (NYSE: TLK) has announced an Extraordinary General Meeting of Shareholders (EGMS) for 2026, scheduled for September 30, 2026, at 14.00 Western Indonesia Time, to be held online. Shareholders recorded by September 7, 2026, at 16.15 Western Indonesia Time, are eligible to attend, …
Rp49,858,000,000,000 fiber unit spin-off for Telkom Indonesia (NYSE: TLK)
Telkom Indonesia (NYSE: TLK) plans a non-liquidating spin-off of its Phase 2 Wholesale Fiber Connectivity Business Segment to its controlled subsidiary, PT Telkom Infrastruktur Indonesia (TIF). This segment is valued at Rp49,858,000,000,000, representing 33% of Telkom's equity as of December 31, 2025. The spin-off …
Republic Services Inc. stock outperforms competitors on strong trading day
Shares of Republic Services Inc. (RSG) rose 2.37% to $214.56 on Friday, outperforming the broader market. This marks the stock's second consecutive day of gains. The S&P 500 Index (SPX) increased by 0.62%, and the Dow Jones Industrial Average (DJIA) rose by 0.28% on …
CCORF Maintains KORU Medical Systems(KRMD.US) With Buy Rating, Maintains Target Price $6
CCORF has reiterated its Buy rating for KORU Medical Systems (KRMD.US) and maintained its target price at $6. This indicates a continued positive outlook on the company's stock performance from CCORF.